Portfolio company
Upfront Diagnostics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops rapid point-of-care blood tests for stroke identification, serving paramedics, emergency medical services, and hospital clinicians.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
StrokeDx
This company develops portable, non-invasive neuroimaging devices and software for rapid bedside stroke detection and monitoring for healthcare providers and emergency services.
AI Stroke
This company develops a mobile application using artificial intelligence and video analysis to assist paramedics and emergency departments in detecting strokes.
Wellumio
This company develops portable magnetic resonance brain scanners for emergency medical providers to diagnose acute strokes at the point of care.
Biomedical Solutions
This company develops endovascular thrombus removal devices for healthcare providers to treat patients suffering from acute ischemic stroke.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
Advanced Perfusion Diagnostics
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
FluoretiQ Limited
This company develops rapid point-of-care diagnostic tests that identify bacterial infections and antibiotic sensitivity for clinicians and veterinarians.
Slive
This company develops point-of-care diagnostic tests for clinicians to improve the speed and accuracy of medical screenings.
